AHFS Drug Information June 2023 Update

This update contains 3 new monographs, 24 revised monographs and 18 new MedWatch alerts.

New monographs: Leniolisib; Retifanlimab-dlwr; Trofinetide.

Revised monographs: Abaloparatide; Antihemophilic Factor (recombinant), Glycopegylated-exei; Cladribine (Antineoplastic Agent); Cladribine (Immunomodulatory Agent); COVID-19 Vaccine (Moderna); COVID-19 Vaccine (Pfizer-BioNTech); Darbepoetin Alfa; Epoetin Alfa; Eszopiclone; Lenalidomide; Mavacamten; Mecasermin; Nirmatrelvir and Ritonavir; Pomalidomide; Remimazolam; Sirolimus (topical); Sirolimus, albumin-bound; Teriparatide; Thalidomide; Topiramate; Treprostinil; Voxelotor; Zaleplon; Zolpidem.

New MedWatch alerts on the following monographs: Buprenorphine; Butorphanol; Codeine; fentaNYL; HYDROcodone; HYDROmorphone; Levorphanol; Meperidine; Methadone; Morphine; Oliceridine Fumarate; Opiate Agonists General Statement; oxyCODONE; oxyMORphone; Pentazocine; Propofol; Tapentadol; traMADol.